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Synovial fluid analysis is utilized to diagnose septic synovitis. However, not all cases
are clearly and rapidly discernible with the diagnostic tools available in the laboratory.
Serum amyloid A (SAA), an acute phase protein, has been shown to be elevated in
synovial fluid from inflamed synovial structures. The goal of this study is to describe the
correlation between two diagnostic tests measuring equine SAA levels in septic and non-
septic synovial structures and to understand the correlation between an elevated SAA
result and synovial sepsis. Prospective estimation of sensitivity (Se) and specificity (Sp)
of two tests, handheld and ELISA, measuring SAA in synovial fluid was completed in
62 horses presented with injured synovial structures. The comparison was made to a
reference diagnosis based on white cell count, percentage of neutrophils, intracellular
bacteria and bacterial culture on synovial fluid. Handheld test levels were classified as:
4 lines visible—SAA level negative; 3 lines visible—SAA level mild; 2 lines visible—SAA
level moderate; and 1 line visible—SAA level severe and compared to the numerical
value obtained with ELISA test. The ELISA SAA test had an area under the curve of
0.88 (0.78–0.98). An ELISA cut-off of 23.95µg/mL maximized Se and Sp. This cutoff
gave a Se of 0.93 (0.66–1.00) and Sp of 0.77 (0.63–0.88). The handheld test was highly
correlated with the ELISA SAA test (Spearman rank correlation 0.96) and at a cutoff of
moderate or higher for positive results gave identical Se and Sp. Se and Sp of synovial
fluid SAA are very reliable when clinical signs of synovitis are present for >6 h. This test,
in conjunction with traditional methods, can assist practitioners to rapidly diagnose and
expedite appropriate intervention of synovial sepsis.
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INTRODUCTION
Investigation of synovitis is frequently undertaken in equine
veterinary practice (1). Due to the high morbidity (6–50%)
and mortality (10–55%) associated with synovial sepsis (2–9),
rapid differentiation between septic and non-septic synovitis
should be considered a priority, so that appropriate and timely
interventions can be instituted (2, 9). In cases of synovial sepsis,
clinical signs can be variable depending on numerous factors
such as size and species of the bacterial inoculum (4, 10), duration
of infection (11), and treatment with anti-inflammatories and/or
antimicrobials (12, 13). A highly sensitive and specific “gold
standard” laboratory test for synovial sepsis is not currently
available and will be difficult to obtain due to the complicated
etiopathology of sepsis (10). Accurate classification of synovitis
relies on a range of diagnostic techniques, including cytological
analysis and bacterial culture of synovial fluid (4, 5, 8, 14–
16). Positive bacterial culture and confirmation of intracellular
bacteria within the neutrophils are two parameters considered
definitive of sepsis (5, 6, 15, 17, 18). However, the Se of
either parameters is low (4, 5, 17, 18), reported to be 23–
31% for bacterial culture and not reported for identification of
intracellular bacteria in the authors’ knowledge but also low in
their experience. Presumptive diagnosis of sepsis is made with
cytological evidence of marked leukocytosis with neutrophilic
inflammation (5–30 × 109 nucleated cells/L), percentage of
neutrophils from 80 to 90% and total protein above 40 g/L (4–
7, 15, 17, 18). Based on the nature of the diagnostic test currently
available, reporting cytological and bacteriological results can
take up to 3–4 days. This delay can have severe consequences
on the diagnosis, prognosis and outcome of the clinical case
presented (5).
In the case of joint trauma, the acute phase response is the
first inflammatory reaction acting as a barrier for pathogens and
preventing further entry while decreasing tissue damage and
stimulating the repair processes (19). Serum amyloid A (SAA) is
an apolipoprotein with three isoforms SAA1, SAA2, and SAA3.
Isoforms SAA1 and SAA2 are produced by hepatocytes and
SAA3 by extrahepatic sites including synoviocytes in response to
inflammatory, infectious, immunological conditions and trauma
(20–22). It has a low physiological presence in the healthy horse,
<5µg/mL in normal synovial fluid, but has been shown to be
elevated and rise up to 1,000-fold during acute inflammatory
phases (20–22). Its increase has been reported not only in
musculoskeletal diseases, septic or non-septic inflamed synovial
joint conditions, but also on a variety of medical conditions
including gastrointestinal and reproductive (23, 24).
Equine SAA levels, proportionate to the degree of insult, have
been detected in serum (23–26) and in synovial fluid (10, 22,
25, 26). The use of a SAA handheld test has been previously
reported on a model of a synovitis and septic arthritis (25)
but not in a clinical environment. In the present study, clinical
cases were used to evaluate the diagnostic accuracy of two tests,
an enzyme-linked immunosorbent assay (ELISA) commercially
available and validated in the horse and a semi-quantitative
handheld test, measuring synovial fluid SAA from septic and
non-septic synovial structures. We hypothesized that SAA would
be significantly higher in septic vs. non-septic synovial structures
and that both tests would differentiate septic from non-septic
synovial structures with a high level of diagnostic accuracy. We
also hypothesized that time of sampling relative to the onset
of clinical signs and treatment administered prior to sampling
would affect the accuracy of the SAA tests.
MATERIALS AND METHODS
Participants
Synovial fluid samples from 62 horses, with clinical signs
of synovitis (perisynovial swelling or synovial effusion) and
lameness presented from August 2012 to December 2013 were
included in the study. The median age of the horses was 4.5
years (range 3 days−23 years). Thirty female horses and 32
geldings were included in the study consisting of the following
breeds: Irish Sport Horse (n = 35), Thoroughbred (n = 14),
Standardbred (n = 5), pony (n = 3), Irish Draft Horse (n =
2), Cob (n = 2), and Quarter Horse (n = 1). All synovial fluid
samples were harvested as part of the routine work-up of the
cases. All owners consented in writing to this work-up and that
samples collected could be used for research purposes.
Diagnosis
Investigation of synovial structures consisted of physical
examination, radiography, ultrasonography, synovial fluid
aspiration for analysis and synovial pressure-leak testing in
cases where the synovial membrane may have been breached as
previously described (8, 16). Administration of antimicrobial or
anti-inflammatory treatments prior to sampling was recorded.
Synovial structures were given the reference diagnosis of septic
(S) if they met one of the following criteria: synovial fluid
positive for bacterial culture; intracellular bacteria observed
on cytology; or evidence of marked neutrophilic synovial
inflammation (percentage neutrophils (%N) >80%, nucleated
cell count (NCC) >30 × 109 nucleated cells/L) and total
protein (TP) >40 g/L). Synovial structures were considered
non-septic (NS) if synovial fluid was negative for bacterial
culture, intracellular bacteria was not observed on cytology, and
if there was evidence of mild neutrophilic synovial inflammation
(percentage neutrophils (%N)<80%, nucleated cell count (NCC)
< 30× 109 nucleated cells/L) and total protein <40 g/L).
Sample Processing
Synovial fluid samples were obtained by routine aseptic
technique. The sample was divided into 2 EDTA blood collection
vials and 1 collection in a blood culture bottle (Oxoid Signal
blood culture system, Oxoid microbiological products, Thermo
Fisher, Hampshire, UK) or in a plain tube if the volume
available was <10ml. Cytology was performed within 12 h on 1
EDTA sample and the following parameters determined: NCC,
%N, TP, and presence of intracellular bacteria. The NCC was
determined using a Neubauer chamber after treating synovial
fluid with hyaluronidase solution (Sigma Aldrich, UK). The
other cytological parameters were determined by examination
of direct smears and cytospin samples, stained with a modified
Romanowsky stain, by a board-certified clinical pathologist. TP
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was quantified on EDTA samples by a clinical refractometer
(Atago, Japan). Bacterial culture was performed on plain
samples or blood culture samples using MacConkey and blood
agar. Blood culture samples were processed according to the
manufacturer’s guidelines. The second EDTA sample was frozen
for 1–2 months at−20◦C until SAA quantification.
SAA Analysis
After thawing at room temperature, samples were subjected to
2 tests determining synovial fluid SAA levels: a commercially
available multispecies ELISA validated in the horse (Accuplex
Diagnostics, Kildare, Ireland) and a handheld test (EquiCheck,
Accuplex Diagnostics, Kildare, Ireland). The operators
processing the SAA tests were blind to the clinical signs and
reference diagnosis, and blind to the results of each test. For the
ELISA methodology, samples were diluted 1:500 in PBS Tween
and 100 µL added along with standards and controls to a 96-well
plate. All samples were analyzed in duplicate. The plate was
incubated at 37◦C for 1 h before washing 4 times using 300 µL of
PBS Tween per well. After removal of excess wash solution, 100
µL of a ready-to-use horseradish peroxidase labeled monoclonal
antibody was added to the wells and the plate incubated for a
further 30min at 37◦C. The wells were then washed with PBS
Tween before addition 100 µL teramethylbenzidine substrate
for 10min. The reaction was stopped by addition of 100 µL
of 0.1M sulfuric acid and the plate was read at an absorbance
of 450 nm. Standards were an equine serum sample calibrated
to purified equine serum SAA. Where samples were above the
highest standard, these were further diluted and retested to
obtain the level of SAA. The lowest detectable measure of SAA
was 1µg/mL. Results <5µg/mL were reported as <5µg/mL.
The ELISA intra-assay variation was <2% and the inter-assay
variation was <7%, indicating high performance of the test.
The handheld test, a lateral flow immunochromatographic test
strip, designed for detection of SAA in whole blood samples, uses
competitive assay format, without the need for sample dilution.
Five microliters of synovial fluid were added to the test window,
followed by addition of 3 drops of solution supplied with the
test kit. After 10min the test was interpreted by counting the
visible red lines in the test window. SAA levels were determined
as follows: all 4 lines visible—SAA level negative; 3 lines visible—
SAA level mild; 2 lines visible—SAA level moderate; and 1 line
visible—SAA level severe. If no red line was visible, the handheld
test was considered invalid and was repeated.
Data Analysis
Standards for Reporting Diagnostic accuracy studies (STARD)
2015 check list was used in this study as a guide to
contribute to the completeness and transparency of reporting
the diagnostic accuracy of the SAA measurement. For horses
presenting more than one synovial structure harvested, just
one has been chosen randomly to reduce bias in estimated
confidence intervals.
ELISA SAA data was compared using Mann-Whitney U test
as the values were highly right skewed. Diagnostic performance
of the ELISA and handheld tests over a range of cut-off values
was described using receiver operating characteristic (ROC)
curves with the reference diagnosis as the “gold standard.” Area
under the curve (AUC) and an estimate of its 95% bootstrap
confidence interval (CI) for each ROC curve was also determined
using the pROC package (10,000 samples) (27), within the
R statistical system (28). A preliminary cut-off for both SAA
tests was then selected, maximizing the sum of Se and Sp
(Youden’s Index). Using the same cut off values, test Se and
Sp was calculated for synovial structures of horses that were,
and were not, treated with antibiotics and/or anti-inflammatories
within 48 h preceding synoviocentesis, and for horses showing
clinical signs ≤6 h and >6 h. A scatterplot and Spearman’s rank
correlation was used to assess the correlation of both SAA tests.
Uncertainty of estimates of Se and Sp were estimated with
binomial exact confidence intervals. Statistical analysis using a
random single limb of each horse yielded results that did not
differ markedly compared to results of analysis of all structures,
when treated independently.
Statistical significance was set at p < 0.05.
RESULTS
Diagnosis
Of the 62 horses, 48 (77%) were categorized as NS and 14
(23%) as S based on synovial fluid positive for bacterial
culture, intracellular bacteria observed on cytology, or
evidence of marked neutrophilic synovial inflammation.
Synovial fluid submitted for culture revealed 8 positives
for bacteriology including Streptococcus zooepidemicus (x2),
Streptococcus dysagalactiae, Actinobacillus suis, Streptococcus
dysgalactae, Rhodococcus equi, Escherichia coli, Coagulase
negative Staphylococci and 4 of those samples had intracellular
bacteria detected on cytology too. Four cases were categorized
as septic based on synovial inflammation only. Affected
anatomical sites consisted of 43 joints, 16 tendon sheaths and
3 bursae. Twenty-eight (45%) cases had been treated with
anti-inflammatories within 48 h preceding synoviocentesis (NS:
n = 22; S: n = 6). Thirty-one (50%) cases had been treated with
antimicrobials within 48 h preceding synoviocentesis (NS: n =
22; S: n= 9).
SAA Levels
ELISA SAA results for the S group (mean: 1,017, median:
229, interquartile range (IQR) 1,290µg/mL) were significantly
different from the NS group results (mean: 70.2, median: 5, IQR:
11.2µg/mL) (p < 0.001). Of the 48 NS structures, 37 (77%) had
negative SAA on handheld, 3 (6%) hadmild, 3 (6%) hadmoderate
and 5 (10%) had severe SAA levels. Of the 14 S structures on
handheld testing 1 (7%) had negative SAA, 3 (21%) had mild, 2
(14%) had moderate, and 8 (57%) had severe SAA levels. ELISA
and handheld test results were highly correlated, Spearman’s rank
correlation 0.96 (Figure 1).
Sensitivity and Specificity of ELISA and
Handheld SAA for Prediction of Sepsis of
Synovial Structures
The cut-off that maximized Se and Sp for the ELISA was SAA ≥
23.95µg/mL [Se = 0.93 (95% CI 0.63–1) and Sp = 0.77 (95% CI
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0.63–0.88)]. The AUCwas 0.88 (95%CI 0.78–0.98) for the ELISA.
The cut-off that maximized Se and Sp for the handheld test was
SAA≥moderate (1 or 2 lines visible on the test strip). At this cut-
off the handheld test diagnoses were concordant with the ELISA
test and hence had identical Se and Sp results. The AUC was 0.86
(95% CI 0.76–0.96) for the handheld test (Figure 2).
FIGURE 1 | Scatterplot of ELISA SAA values vs. handheld test results with
point shape representing reference diagnosis (Septic (S) synovial structures =
triangles and non-septic (NS) synovial structures = circles). Points are spread
horizontally where ELISA results are similar). ELISA cutoff (23.95) maximizing
the sum of Se and Sp is shown as an additional labeled gridline. The
Spearman rank correlation between ELISA score and ordinal handheld test
score is also shown.
Influence of Synovial Sampling Timing
Relative to Antibiotic and/or
Anti-Inflammatory Treatment Within 48h
Preceding Synoviocentesis
Although not statistically significant, both tests demonstrated
increased performance (AUC) in the untreated groups compared
to treated groups. The performance of the SAA tests increased if
synovial structures were not treated before being analyzed. The
ELISA AUC increased from 0.83 (0.66–1) for samples treated, to
0.97 (0.91–1) for non-treated samples. Regarding the handheld
test, the AUC increased from 0.77 (0.59–0.95) for samples treated,
to 0.97 (0.92–1) for non-treated samples; Correspondingly, Se
and Sp increased from 0.89 (0.52–1) and 0.55 (0.32–0.76) to
1 (0.48–1) and 0.96 (0.8–1), respectively. ELISA testing yielded
identical improved Se and Sp (Figure 3).
Influence of Synovial Sampling Timing
Relative to Onset of Clinical Signs
Unexpectedly low SAA levels (ELISA 5µg/mL; handheld
negative) were detected in 1 horse that met the septic criteria. Its
joint had sustained injury within 6 h of synoviocentesis. Of the
structures showing clinical signs of ≤6 h the highest SAA level
was 903µg/mL (ELISA) and severe (handheld). The performance
of the SAA tests increased if synovial structures from horses
sampled within 6 h of onset of clinical signs were excluded
from the analysis. The AUC increased from 0.68 (0.4–0.97), for
samples taken ≤6 h of onset of clinical signs, to 0.95 (0.89–
1.00) for samples taken after 6 h of onset of clinical signs for the
handheld test and from 0.65 (0.35–0.96) to 0.96 (0.91–1.00) for
ELISA. Correspondingly, Se and Sp increased from 0.75 (0.19–
0.99) and 0.69 (0.39–0.91) to 1.00 (0.69–1.00) and 0.8 (0.63–0.92),
respectively for handheld test with exclusion of the structures
sampled ≤6 h after the onset of clinical signs. ELISA testing
yielded similar improved Se and Sp, with a minor difference in
95% CIs (Figure 4).
FIGURE 2 | Receiver operating characteristic (ROC) curves for ELISA and handheld SAA tests for all 62 horses.
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FIGURE 3 | Receiver operating characteristic (ROC) curves for ELISA and handheld SAA tests for horses that received antimicrobial and/or anti-inflammatory therapy
(T+) and horses that did not (T−).
DISCUSSION
The aim of this investigation was to evaluate the diagnostic
accuracy of two tests measuring synovial fluid SAA in
distinguishing S from NS synovial structures. Synovial fluid
levels of SAA were significantly higher in S structures compared
to NS structures and both tests showed excellent Se (0.93)
and good Sp (0.77) for the diagnosis of sepsis. The ELISA
carries similar disadvantages as routine synovial fluid analysis,
in that substantial time is required to submit, transport, analyze
and report results. In contrast, the handheld test, evaluated
herein, is simple to perform and provides results within minutes
while the veterinarian is horse-side. The results demonstrate the
potential usefulness of the handheld test as a diagnostic tool in
ambulatory settings or out-of-hours in hospitals permitting early
referral or appropriate treatment, while awaiting other laboratory
test results.
Studies of diagnostic accuracy compare the diagnostic
test, synovial fluid SAA ELISA and handheld in this case,
against a gold standard diagnostic test. However, such a test,
distinguishing septic from non-septic synovial structures is not
currently available in horses (10). Thus, this study compares
synovial fluid SAA to a reference diagnosis. To maximize the
accuracy of the reference diagnosis, strict inclusion criteria
were utilized for both categories. Septic structures had positive
bacterial cultures, and/or intracellular bacteria, and/or marked
neutrophilic synovitis and high total protein count. All S
structures were treated as septic with appropriate aggressive
medical and surgical interventions. Whilst 32 structures in the
NS group had a high index of suspicion of sepsis due to clinical
signs of effusion, heat, pain or swelling, and marked lameness in
the associated limb (i.e., lame at the walk), it should be noted that
for not all NS cases synovial sepsis was high on the differential list.
Inclusion of these cases led to the incorporation of NS structures
that had low levels of synovitis.
The AUC is a measure of the diagnostic accuracy of a test,
and describes the performance of the test over all possible
cut-offs. Once synovial structures sampled ≤6 h from onset
of clinical signs, were excluded, the AUC of the ELISA and
handheld tests were 0.96 and 0.95, respectively. Diagnostic tests
with an AUC >0.9 are described as “highly accurate” (28).
Analysis of the ROC curves, and consideration of the costs
associated with false negative and false positive results were
used to establish the cut-off values. Cut-offs were selected that
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FIGURE 4 | Receiver operating characteristic (ROC) curves for ELISA and handheld SAA tests for horses tested within 6 h (<6 h) and horses tested after 6 h (>6 h) of
the onset of the clinical symptoms.
maximized the sum of Se and Sp. Survival and return-to-
soundness rates following synovial sepsis have been reported as
45–90% and 50–94%, respectively (2, 4–8). Thus, in synovial
sepsis, ensuring a minimum number of septic synovial structures
are misdiagnosed as non-septic (i.e., false negatives) is important.
Higher test sensitivities would have been preferential, but due to
the distribution of our data, further lowering of the cut-offs in
case of the ELISA, and lowering of the cut-offs in case of the
handheld test, led to a proportionately greater reduction in the
Sp. Se increased to 1 when synovial structures with clinical signs
of ≤6 h were excluded.
Possible explanations for septic cases revealing low SAA
include: failure of the individual to mount an acute phase protein
response (25); or suppression/reduction of SAA production as
a result of medical therapy (22, 29). SAA production increases
in response to release of pro-inflammatory cytokines IL-6, IL-1,
and TNF-α (30). In humans, tetracyclines have been reported to
inhibit pro-inflammatory mediators (matrix metalloproteinases,
TNF-α, and IL-1) and to inhibit neutrophils and T-lymphocytes.
Non-steroidal anti-inflammatories also decrease these pro-
inflammatory mediators by inhibiting cyclooxygenase resulting
in reduced SAA levels (19, 29, 31, 32). As an example, a
chronically septic tarsal sheath had low SAA. This horse was
being treated with oxytetracycline (6 mg/kg intravenously once
daily) and phenylbutazone (2.2 mg/kg per os twice daily)
when sampled. A similar mechanism of SAA “suppression” was
observed for a septic middle carpal joint case. This joint was
injected with corticosteroid (betamethasone 6mg) 1 week prior
to sampling.
In an experimental model of acute neutrophilic synovitis,
synovial fluid SAA levels were not increased, or only mildly
increased, at 4 and 8 h post intraarticular lipopolysaccharide
injection, peaking at 48 h (22). It is likely that SAA in the
described horse had not increased within the 6 h from injury to
synoviocentesis. In light of this finding, we do not recommend
the use of synovial fluid SAA testing in horses with clinical
signs of ≤6 h. Synovial structures in horses with an unknown
history and strong clinical suspicion of sepsis but unexpectedly
low synovial fluid SAA should be retested 6 h later. Irrespective
of synovial fluid SAA all open synovial structures should receive
appropriate surgical and medical interventions in line with
previous reports (1, 2, 4, 8, 9).
Three SAA isoforms predominate in synovial fluid: SAA 3,
produced by the synovial membrane and SAA 1 and SAA 2,
synthesized by the liver accessing the synovial fluid from the
systemic circulation (22, 33). As neither SAA test in our study
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distinguished between SAA isoforms, it is possible that elevations
in synovial fluid SAA, in these structures, represent systemic
elevation of SAA brought about by the septic focus. Alternatively,
“sympathetic” inflammatory response in the synovial structures,
induced by the proximity of a septic process, may have
increased local SAA synthesis (34–36). When encountering
modest increases in synovial fluid SAA, where a septic process
is adjacent to the synovial structure, the practitioner may
choose to increase the test cut-off and thus improve the Sp
of the test. Simultaneous analysis of blood and synovial fluid
SAA, as well as refinement of the handheld test to specifically
detect SAA 3 may be beneficial in decreasing false positives in
the future.
In the clinical context, interpretation of the synovial SAA
results can be challenging. For instance, SAA levels in an NS
tarsocrural joint of a 4-day-old foal were moderately elevated
on the handheld test. The ELISA test demonstrated a mild
increase in SAA (98µg/mL) but above the cut off (23.95µg/mL)
and would therefore have led to the conclusion of a septic
process based on SAA results. This foal had pleuropneumonia
and a fractured rib, both of which may have increased systemic
SAA. Unfortunately, SAA measurement in the blood was not
performed in this study but could have been useful in such
a case.
On clinical cases, it is not uncommon to have several effused
synovial structures in a close vicinity. In the current study,
synoviocentesis of all effused synovial structures was performed
but just one randomized anatomical structure per horse was used
for the statistical analysis. In order to provide further insight
on the clinical cases, it was decided to highlight the challenges
associated with interpretation of the SAA results; as an example,
a 5-month-old Thoroughbred with clinical signs of 3 days
duration, attributable to septic osteitis of a proximal sesamoid
bone, had moderate handheld SAA values and SAA of 135.5 and
144.7µg/mL (ELISA), respectively, for the digital flexor tendon
sheath and the metacarpophalangeal joint, of the same limb.
Those two synovial structures adjoining the infected sesamoid
bone were categorized as NS but modest increases in SAA would
have led to conclude they were potentially septic. Another horse
sustained a penetrating wound to the hock region and developed
a latero-plantar periarticular abscess associated with tarsocrural
joint infection. The tarsocrural joint was referenced as S and the
tarsal sheath as NS. SAA levels in the tarsocrural joint and the
tarsal sheath were 730 and 177µg/mL, respectively. Handheld
SAA levels were severe and moderate, respectively. Both synovial
structures based on SAA testing would have been considered
septic, while only the joint was truly infected. Focal infection
can lead to false positive in the adjoining synovial structures
and this should be kept into account while interpreting the
results. As a clinician, assuming a synovial structure is septic
and to treat it as such until proven otherwise is a very safe
approach, as the consequences of not treating a false negative
are greater that treating a false positive. None of the diagnostic
tests including SAA measurement in the synovial fluid (ELISA
or handheld) is truly “diagnostic” as a gold standard. The weight
of the inadequacy of a single test to reach a diagnosis is usually
reduced by performingmultiple diagnostic tests assessing various
angles of a condition. The results of all the diagnostic tests
assessing synovial sepsis should be taken together, rather than as
one conclusive test, to make reasonable clinical decisions.
CONCLUSION
SAA levels were significantly higher in S vs. NS synovial
structures. Overall test performance improved drastically from
sufficient to excellent (37) if synovial samples were taken 6 h after
the onset of clinical signs and more discreetly from very good
to excellent (37) when no antibiotic and/or anti-inflammatory
treatment was administered prior to synoviocentesis. A strong
correlation between ELISA and handheld results was identified.
Quantification of synovial fluid SAA levels via the handheld test
represents an innovative and practical diagnostic tool for equine
practitioners in an ambulatory setting allowing prompt diagnosis
of septic synovial structures, while awaiting confirmation of
the diagnosis from laboratory synovial fluid analysis and
bacteriology. The handheld test may also be beneficial in referral
hospitals for rapid case triage.
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